Kristin Breitschopf

Title: Kristin Breitschopf: Innovator in Pharmacological Compounds

Introduction

Kristin Breitschopf is a notable inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that serve as inhibitors of soluble epoxide hydrolase. With a total of two patents to her name, her work is paving the way for advancements in medical therapies.

Latest Patents

Kristin's latest patents include "Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase." This invention relates to compounds that are highly potent and selective inhibitors, suitable for treating conditions such as renal failure, diabetic nephropathy, type 2 diabetes mellitus, and cardiovascular diseases. The compounds are also beneficial in managing pain, dyslipidemia, atherosclerosis, wound healing, and stroke. Another significant patent is "Isomannide derivatives as inhibitors of soluble epoxide hydrolase," which similarly focuses on pharmacologically active compounds that can aid in the therapy and prophylaxis of various health issues.

Career Highlights

Kristin Breitschopf is currently employed at Sanofi, a leading global healthcare company. Her work at Sanofi emphasizes her commitment to developing innovative solutions in the pharmaceutical industry.

Collaborations

Throughout her career, Kristin has collaborated with talented professionals, including Maria Mendez-Perez and Katrin Lorenz. These collaborations have likely contributed to her success in the field.

Conclusion

Kristin Breitschopf's innovative work in pharmacological compounds showcases her dedication to improving health outcomes through scientific advancements. Her patents reflect her expertise and commitment to addressing critical medical challenges.